ADMA Biologics ADMA Change in Inventories
Change in Inventories at other companies
Other financials
Where this comes from
Reported directly by ADMA Biologics in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInInventories.
The official record: ADMA Biologics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about ADMA Biologics's change in inventories.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is ADMA Biologics's change in inventories?
- ADMA Biologics (ADMA) reported change in inventories of $15.63M in Q1 2026.
- How has ADMA Biologics's change in inventories changed year-over-year?
- ADMA Biologics's change in inventories increased by 700.5% year-over-year, from $1.95M to $15.63M.
- What is the long-term trend for ADMA Biologics's change in inventories?
- Over 4 years (2021 to 2025), ADMA Biologics's change in inventories has grown at a -4.3% compound annual growth rate (CAGR), from $43.19M to $36.23M.
- What does change in inventories mean?
- Increase or decrease in inventory levels, directly affecting operating cash flow and working capital.